As compared with the HCC group, AST, ALT, total bilirubin, AFP, and DCP were significantly lower (p<0.001) in the Non-HCC group, although albumin, prothrombin time (PT) and platelet count were significantly higher (p<0.001). This evidence concerns the gene F2 and hepatocellular carcinoma.